MeSH tree: C17.800.329.937.122
Alopecia areata (AA) has a severe psychosocial impact, which is linked to illness perceptions and stigma more strongly than disease severity, according to a study published online July 16 in the British Journal of Dermatology.
Jul 24, 2025
0
13
The stigma of having alopecia causes more depression and anxiety than the disease itself, new research has found.
Jul 15, 2025
0
17
Patients with higher-severity alopecia areata (AA) have a higher prevalence and incidence of comorbid atopic dermatitis (AD), according to a study published online June 26 in the Journal of Investigative Dermatology.
Jul 14, 2025
0
13
Hair loss is one of the most feared and traumatic side effects of cancer chemotherapy treatment, both for patients themselves and their loved ones, as it can visibly represent the "face of cancer."
Jul 10, 2025
0
14
A quick spray of medication might seem like an easy way to get thicker hair, but some folks say one sold online has left them battling sexual side effects, depression and even thoughts of suicide.
Apr 24, 2025
0
27
Alopecia is an autoimmune disorder that causes non-scarring hair loss on the scalp and body that is experienced by almost 2% of the global population at some point in their lifetime.
For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study presented at the annual meeting of the American Academy of Dermatology, held from March 7 to 11 in Orlando, ...
Mar 19, 2025
0
11
Ancient Egyptians rubbed their bald heads with a mixture of dates, dog's paw and donkey's hoof; Celtic cures involved mice in a jar. Native Americans turned to yucca juice. Throughout human history, there have been a number ...
Mar 14, 2025
1
1240
For adults with severe alopecia areata (AA), ivarmacitinib, a selective Janus kinase 1 (JAK1) inhibitor, at doses of 4 and 8 mg is efficacious and tolerable, according to a study presented at the annual meeting of the American ...
Mar 13, 2025
0
19
A research group, led by Dr. Pavel Majer from IOCB Prague, in collaboration with the laboratories of Barbara Slusher and Louis Garza at Johns Hopkins University, has developed a compound that could potentially treat the autoimmune ...
Mar 13, 2025
0
49
